Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M van Putten

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1986
Of tumours in mice and men, the different roles of somatic mutation in treatment failureL M van Putten
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1975
Problems in the treatment of slow-growing tumorsL M Van Putten
Radiologia Clinica Et Biologica|January 1, 1970
The oxygenation of tumour cells during fractionated irradiationL M van Putten
Cancer Treatment Reviews|March 1, 1984
The experimental basis for combination chemotherapyL M van Putten
Cell and Tissue Kinetics|September 1, 1974
Are cell kinetic data relevant for the design of tumour chemotherapy schedules?L M van Putten
European Journal of Cancer|February 1, 1971
Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustardL M van Putten, P Lelieveld
Cancer Chemotherapy and Pharmacology|January 1, 1978
New cancer chemotherapy drugs in EuropeG Mathé, L M van Putten
Cancer Treatment Reports|April 1, 1976
Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271)P Lelieveld, L M van Putten
European Journal of Cancer|August 1, 1970
Factors determining cell killing by chemotherapeutic agents in vivo. I. CyclophosphamideL M van Putten, P Lelieveld
The British Journal of Cancer. Supplement|June 1, 1978
Misonidazole with small dose fractions in an experimental osteosarcomaL M van Putten, T Smink
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Cancer & Clinical Oncology|July 1, 1986
Of tumours in mice and men, the different roles of somatic mutation in treatment failureL M van Putten
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1975
Problems in the treatment of slow-growing tumorsL M Van Putten
Radiologia Clinica Et Biologica|January 1, 1970
The oxygenation of tumour cells during fractionated irradiationL M van Putten
Cancer Treatment Reviews|March 1, 1984
The experimental basis for combination chemotherapyL M van Putten
Cell and Tissue Kinetics|September 1, 1974
Are cell kinetic data relevant for the design of tumour chemotherapy schedules?L M van Putten
European Journal of Cancer|February 1, 1971
Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustardL M van Putten, P Lelieveld
Cancer Chemotherapy and Pharmacology|January 1, 1978
New cancer chemotherapy drugs in EuropeG Mathé, L M van Putten
Cancer Treatment Reports|April 1, 1976
Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271)P Lelieveld, L M van Putten
European Journal of Cancer|August 1, 1970
Factors determining cell killing by chemotherapeutic agents in vivo. I. CyclophosphamideL M van Putten, P Lelieveld
The British Journal of Cancer. Supplement|June 1, 1978
Misonidazole with small dose fractions in an experimental osteosarcomaL M van Putten, T Smink
Pageof 8